Suppr超能文献

美国消除麻疹后时期的麻疹疫情。

Measles in the United States during the postelimination era.

机构信息

Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.

出版信息

J Infect Dis. 2010 Nov 15;202(10):1520-8. doi: 10.1086/656914. Epub 2010 Oct 7.

Abstract

BACKGROUND

Measles affected entire birth cohorts in the prevaccine era but was declared eliminated in the United States in 2000 because of a successful measles vaccination program.

METHODS

We reviewed US surveillance data on confirmed measles cases reported to the Centers for Disease Control and Prevention and data on national measles-mumps-rubella (MMR) vaccination coverage during postelimination years 2001-2008.

RESULTS

During 2001-2008, a total of 557 confirmed cases of measles (annual median no. of cases, 56) and 38 outbreaks (annual median no. of outbreaks, 4) were reported in the United States; 232 (42%) of the cases were imported from 44 countries, including European countries. Among case-patients who were US residents, the highest incidences of measles were among infants 6-11 months of age and children 12-15 months of age (3.5 and 2.6 cases/1 million person-years, respectively). From 2001 through 2008, national 1-dose MMR vaccine coverage among children 19-35 months of age ranged from 91% to 93%. From 2001 through 2008, a total of 285 US-resident case-patients (65%) were considered to have preventable measles (ie, the patients were eligible for vaccination but unvaccinated). During 2004-2008, a total of 68% of vaccine-eligible US-resident case-patients claimed exemptions for personal beliefs.

CONCLUSIONS

The United States maintained measles elimination from 2001 through 2008 because of sustained high vaccination coverage. Challenges to maintaining elimination include large outbreaks of measles in highly traveled developed countries, frequent international travel, and clusters of US residents who remain unvaccinated because of personal belief exemptions.

摘要

背景

在疫苗接种前时代,麻疹影响了所有出生队列,但由于麻疹疫苗接种计划的成功,美国于 2000 年宣布消除麻疹。

方法

我们审查了美国向疾病控制与预防中心报告的确诊麻疹病例的监测数据,以及消除麻疹后 2001-2008 年期间全国麻疹-腮腺炎-风疹(MMR)疫苗接种覆盖率的数据。

结果

2001-2008 年,美国共报告 557 例确诊麻疹病例(年中位数病例数为 56 例)和 38 起暴发(年中位数暴发数为 4 起);232 例(42%)病例来自 44 个国家,包括欧洲国家。在为美国居民的病例患者中,麻疹发病率最高的是 6-11 个月龄和 12-15 个月龄的婴儿(分别为每 100 万人年 3.5 和 2.6 例)。2001 年至 2008 年,19-35 个月龄儿童的全国 1 剂 MMR 疫苗接种率在 91%-93%之间。2001 年至 2008 年,共有 285 名(65%)美国居民病例患者被认为患有可预防的麻疹(即患者有资格接种疫苗但未接种)。2004-2008 年,68%的符合条件的美国居民病例患者因个人信仰而声称豁免接种疫苗。

结论

由于持续高疫苗接种率,美国在 2001 年至 2008 年期间保持了麻疹消除状态。维护消除麻疹的挑战包括发达国家麻疹大规模暴发、频繁的国际旅行以及因个人信仰豁免而未接种疫苗的美国居民聚集。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验